Stockwatch: Details Differ Between Pfizer And AstraZeneca's Second-Quarter Earnings Reports
As Analysts’ Low Expectations Continue To Beaten, Differences Remain In Big Pharma Earnings And Guidance
Executive Summary
Investors in pharmaceutical companies appreciate details such as sales force dynamics, price-volume relationships and channel-stocking effects. Their absence can make investors wary.